Codoñer-Franch P, Murria-Estal R, Tortajada-Girbés M, del Castillo-Villaescusa C, Valls-Bellés V, Alonso-Iglesias E
Department of Pediatrics, Dr Peset University Hospital, and Department of Pediatrics, Obstetrics and Gynecology, Faculty of Medicine and Odontology, University of Valencia, Valencia, Spain.
Nutr Hosp. 2010 Sep-Oct;25(5):845-51.
The aim of this prospective study was to evaluate the utility of new biochemical markers to assess cardiometabolic risk in severely obese children and adolescents. A total of 107 subjects aged 7 to 14 years, were clinically assessed and anthropometric measures and percentage of fat mass by single frequency bioimpedance analysis were recorded. Of these, 44 were non-overweight and 63 severely obese (body mass index Z-score>2.5) which were stratified by Tanner stages. To estimate the metabolic risk the following variables were considered for analysis: Waist circumference/height>0.5, fasting glucose>100 mg/dL, triglycerides>110 mg/dL, HDL-C<40 mg/dL, and systolic or diastolic blood pressure>95th percentile for age and gender. Fasting insulinemia, apoprotein A1 and B, high-sensitive C-reactive protein, alanine aminotransferase, homocysteine, and folic and uric acids were determined. In severely obese children, metabolic risk was present more frequently in mid puberty. The normalized anthropometric parameters with respect to 50th percentile for age and gender did not differ in the presence of metabolic risk. Insulin resistance was an independent determinant of metabolic risk, adjusted by Tanner stages. Elevated high-sensitive C-reactive protein was noted without any effect of metabolic risk or pubertal stage. Homocysteine, apoprotein B, and alanine aminotransferase values increased with metabolic risk and were not influenced by puberty. Although insulin resistance remains the main factor influencing metabolic risk, biochemical markers as homocysteine, apoprotein B, and alanine aminotransferase, may be useful for identifying severe obese pubertal subjects particularly prone to comorbidities.
这项前瞻性研究的目的是评估新的生化标志物在评估重度肥胖儿童和青少年心脏代谢风险方面的效用。共有107名7至14岁的受试者接受了临床评估,并记录了人体测量指标以及通过单频生物电阻抗分析得出的体脂百分比。其中,44名非超重者和63名重度肥胖者(体重指数Z评分>2.5)按坦纳分期进行了分层。为了评估代谢风险,分析时考虑了以下变量:腰围/身高>0.5、空腹血糖>100mg/dL、甘油三酯>110mg/dL、高密度脂蛋白胆固醇<40mg/dL,以及收缩压或舒张压高于年龄和性别的第95百分位数。测定了空腹胰岛素血症、载脂蛋白A1和B、高敏C反应蛋白、丙氨酸转氨酶、同型半胱氨酸以及叶酸和尿酸。在重度肥胖儿童中,代谢风险在青春期中期更为常见。相对于年龄和性别的第50百分位数的标准化人体测量参数在存在代谢风险时并无差异。胰岛素抵抗是代谢风险的独立决定因素,经坦纳分期调整后依然如此。高敏C反应蛋白升高,且不受代谢风险或青春期阶段的影响。同型半胱氨酸、载脂蛋白B和丙氨酸转氨酶值随代谢风险增加而升高,且不受青春期影响。尽管胰岛素抵抗仍然是影响代谢风险的主要因素,但同型半胱氨酸、载脂蛋白B和丙氨酸转氨酶等生化标志物可能有助于识别特别容易出现合并症的重度肥胖青春期受试者。